Hengdian Group Capital (HgC) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
2
- Portfolio
-
2
Hengdian Group Capital (HgC) General Information
Company Description
Founded in 2017, Hengdian Group Capital (HgC) is a corporate venture capital arm of Hengdian Capital Management based in Hangzhou, China.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- Hangzhou, Zhejiang
- China
Hengdian Group Capital (HgC) Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| CORXEL Pharmaceuticals | 22-Jan-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Solu Therapeutics | 09-Apr-2025 | Drug Discovery | Clinical Trials - Phase 1 |
Hengdian Group Capital (HgC) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Hengdian Group Capital (HgC) Co-Investors (21)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HBM Healthcare Investments | 1 |
|
|
||
| Invus (Private Equity) |
|
|
|||
| New Enterprise Associates |
|
|
|||
| Pappas Capital |
|
|
|||
| SR One |
|
|
Hengdian Group Capital (HgC) FAQs
-
What is Hengdian Group Capital (HgC)?
Founded in 2017, Hengdian Group Capital (HgC) is a corporate venture capital arm of Hengdian Capital Management based in Hangzhou, China.
-
When was Hengdian Group Capital (HgC) founded?
Hengdian Group Capital (HgC) was founded in 2017.
-
Where is Hengdian Group Capital (HgC) headquartered?
Hengdian Group Capital (HgC) is headquartered in Hangzhou, China.
-
How many investments has Hengdian Group Capital (HgC) made?
Hengdian Group Capital (HgC) has made 2 investments.
-
What has Hengdian Group Capital (HgC) invested in?
Hengdian Group Capital (HgC) has made numerous investments in companies like CORXEL Pharmaceuticals and Solu Therapeutics within the Drug Discovery industry.
-
What has Hengdian Group Capital (HgC) invested in recently?
Hengdian Group Capital (HgC)'s latest investment was on 22-Jan-2026 in CORXEL Pharmaceuticals, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
